Healthcare

Our solutions support the transformation of pharmaceutical companies, medical device manufacturers, biotechs, healthcare providers, healthcare networks and pharmacy chains. They provide robust support in response to developments across pharmaceutical markets, medical devices, digital health, care delivery, prevention and long-term care.

Explore our market reports

The industryOur solutionsUse casePublications

Healthcare systems must respond to growing demand driven by population ageing, the rise in chronic diseases and the shift towards outpatient care.

The digitalisation of care pathways, telemedicine and personalised medicine are reshaping business models and accelerating the development of e-health.
Pharmaceutical companies and medtech players are stepping up investment in innovation, R&D and the reshoring of certain production activities.
Healthcare providers, hospitals and clinics are reorganising their operations to optimise resources and adapt patient care delivery.

Under budgetary, regulatory and social constraints, stakeholders must reconcile access to care, economic performance and innovation.

20 million

number of people in France living with a chronic disease

3 000

number of private MCO, SMR, psychiatric clinics and nursing homes in France

12X

EBITDA valuation multiple of the largest healthcare groups

85%

export rate of in vitro diagnostics manufacturers based in France

From the Expert

A researcher analyzing samples in a biomedical laboratory

« French pharmaceutical laboratories are refocusing their R&D efforts on specialty medicine-oncology, immuno-inflammation, rare diseases, etc. However, many still struggle to compete with global giants. To strengthen their positions in a highly competitive global market, they must activate new levers for consolidation, repositioning and partnerships. »

Cathy Alegria

Healthcare Sector Expert, Xerfi

A group of colleagues exchanging ideas in a workspace

Our solutions for the healthcare industry

Drawing on its recognised expertise in the economy and markets, Xerfi offers a comprehensive range of analysis and advisory solutions. From flagship reports to bespoke analyses, from Call Expert to videos and conferences led by our consultants, we support private and public organisations alike in turning analysis into action.

Economic, regulatory and societal impact reports

To assess the effects of a reform, regulation or innovation on access to care, the structuring of healthcare value chains and overall sector performance.

Analysis of risks and sectoral transformation drivers

To understand the impact of regulatory, technological and demographic developments on healthcare value chains-pharmaceuticals, medical devices, care delivery and long-term care-and to define levers for resilience and adaptation.

Competitive landscape mapping

To visualise the competitive forces at play-pharmaceutical companies, medtech players, healthcare providers, start-ups and networks-assess market shares and identify partnership or external growth opportunities.

Brand awareness studies and brand image audits, marketing mix assessments

To evaluate how your brand, products or healthcare facility are perceived by patients, prescribers and partners, and to define differentiation levers.

Economic and social assessments and contribution analyses

To highlight your economic and social footprint—employment, investment, territorial presence, contribution to the healthcare system and medical innovation.

Hands cupping flowing water - illustrating the healthcare sector

Use case

Optimising the positioning of an innovative medical device in a market undergoing restructuring

Detailed challenge

A manufacturer of specialised medical devices, operating in a rapidly evolving market (shift to outpatient care, pricing pressure, international competition), was planning to launch a new piece of equipment for hospitals and clinics. The company needed a clear perspective to guide its R&D investment and define its go-to-market strategy.

Objectives

Identify the care segments and healthcare facilities most receptive to innovation.
Understand the decision-making criteria of key stakeholders.
Assess the impact of new regulatory frameworks and hospital procurement policies.
Test potential business models and assess their viability.

Solutions

Economic, regulatory and societal impact studies: analysis of the MDR (Medical Device Regulation), reimbursement rules, hospital groups (GHTs) and group purchasing mechanisms to assess their impact on product adoption.
Analysis of risks and sectoral transformation drivers: the shift to outpatient care, pricing pressure, consolidation of private clinics, etc.
Competitive landscape mapping: benchmarking of European players, analysis of competing technologies and emerging innovations.